ARTICLE | Clinical News
Dexmedetomidine regulatory update
October 25, 2010 7:00 AM UTC
The European Medicines Agency accepted for review an MAA from Orion for dexmedetomidine for intensive care sedation. The company expects the review to last over a year. Hospira has rights to the selec...